We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.81 | -3.87580299786 | 46.7 | 46.7 | 37.4968 | 124887 | 41.4913151 | CS |
| 4 | 10.29 | 29.7398843931 | 34.6 | 48.63 | 34.53 | 141174 | 42.64645727 | CS |
| 12 | 25.94 | 136.886543536 | 18.95 | 48.63 | 17.1804 | 125473 | 33.27182854 | CS |
| 26 | 27.99 | 165.621301775 | 16.9 | 48.63 | 15.0001 | 82144 | 30.65728055 | CS |
| 52 | 27.99 | 165.621301775 | 16.9 | 48.63 | 15.0001 | 82144 | 30.65728055 | CS |
| 156 | 27.99 | 165.621301775 | 16.9 | 48.63 | 15.0001 | 82144 | 30.65728055 | CS |
| 260 | 27.99 | 165.621301775 | 16.9 | 48.63 | 15.0001 | 82144 | 30.65728055 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
